financetom
Business
financetom
/
Business
/
MicroStrategy Buys More Bitcoin: What's Going On With The Stock?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MicroStrategy Buys More Bitcoin: What's Going On With The Stock?
Mar 19, 2024 8:59 AM

MicroStrategy Incorporated ( MSTR ) shares are trading lower Tuesday amid a pullback in the price of Bitcoin. The company announced the completion of its previously announced offering and the purchase of additional bitcoins. 

What To Know:

MicroStrategy ( MSTR ) announced it has completed its previously announced offering of 0.875% convertible senior notes due 2031. The aggregate principal amount of the notes sold in the offering was $603.75 million. 

The company also announced that, during the period between March 11 and March 18, it acquired approximately 9,245 additional bitcoins, using $592.3 million of proceeds from the offering, for approximately $623 million in cash, at an average price of approximately $67,382 per bitcoin. 

As of March 18, the company holds approximately 214,246 bitcoins, acquired at an aggregate purchase price of approximately $7.53 billion and an average purchase price of approximately $35,160 per bitcoin.

Bitcoin has pulled back in recent days and is trading at $62,702.66 at the time of publication. 

Related News: Reddit Poised To ‘Pop’ On IPO As Wall Street Eyes ‘Prettiest Girl At The Dance’

MSTR Stock Forecast in 2030:

Predicting the future in stock prices over long periods of time is challenging. Wall Street analysts use complex models that take into account interest rates, economic growth, competitive advantages, management teams and historical profitability, among a host of other factors.

If, as an investor, you want to assume most of the major factors remain stable, you can use trend analysis as a helpful tool. Using a longer term trend line or historical performance of the stock, you can aim to forecast a stock's annual rate of return.

For MicroStrategy ( MSTR ) , over the past 5 years, it's annualized stock performance is 58.63%, and if you assume that trend continues for another 5 years, you can expect a stock to trade at $12,850.88.

Using a trend line (see how to perform this function here), If you choose to use a trend line, connect your two points and look into the future to the point in time in which you're curious. Once you've identified that stock price, you may want to consider what type of conditions would need to exist for the stock to justify the share price – be it an outside influence or managerial decision making.

MSTR Price Action: According to Benzinga Pro, MicroStrategy ( MSTR ) shares are down 11.7% at $1,327.53 at the time of publication.

Image from Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Insmed Insider Sold Shares Worth $1,989,797, According to a Recent SEC Filing
Insmed Insider Sold Shares Worth $1,989,797, According to a Recent SEC Filing
Mar 5, 2025
05:36 PM EST, 03/05/2025 (MT Newswires) -- William Lewis, Director, Chair and CEO, on March 03, 2025, sold 25,580 shares in Insmed ( INSM ) for $1,989,797. Following the Form 4 filing with the SEC, Lewis has control over a total of 618,610 common shares of the company, with 334,186 shares held directly and 284,424 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1104506/000162828025010590/xslF345X05/wk-form4_1741213663.xml...
Hippo Holdings Insider Sold Shares Worth $354,045, According to a Recent SEC Filing
Hippo Holdings Insider Sold Shares Worth $354,045, According to a Recent SEC Filing
Mar 5, 2025
05:37 PM EST, 03/05/2025 (MT Newswires) -- Assaf Wand, Director, Executive Chairman of Board of Directors, on March 03, 2025, sold 12,250 shares in Hippo Holdings ( HIPO ) for $354,045. Following the Form 4 filing with the SEC, Wand has control over a total of 1,170,331 common shares of the company, with 683,517 shares held directly and 486,814 controlled...
Axon Prices Upsized $1.75 Billion Debt Offering
Axon Prices Upsized $1.75 Billion Debt Offering
Mar 5, 2025
05:36 PM EST, 03/05/2025 (MT Newswires) -- Axon Enterprise ( AXON ) said Wednesday it priced an upsized $1.75 billion private offering of senior notes. The offering covers $1 billion principal amount of 6.125% of senior notes due 2030 and $750 million of 6.250% senior notes due 2033, according to the company. Axon said it intends to use the proceeds...
ARS Pharmaceuticals Says US FDA Approves Lower Dosage of Neffy Nasal Spray
ARS Pharmaceuticals Says US FDA Approves Lower Dosage of Neffy Nasal Spray
Mar 5, 2025
05:37 PM EST, 03/05/2025 (MT Newswires) -- ARS Pharmaceuticals ( SPRY ) said the US Food and Drug Administration approved a lower dosage of neffy for allergic emergencies, including anaphylaxis. The regulator approved a 1 milligram version of the nasal spray for children 4 years and up, the company said Wednesday in a statement. A 2 mg version of neffy,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved